Lim; Jong Lae

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lim; Jong Lae.The latest application filed is for "stable pharmaceutical composition comprising esomeprazole and sodium bicarbonate".

Company Profile

4.3.22

Lim; Jong Lae - Yongin-si Gyeonggi-do KR
LIM; Jong Lae - Yongin-si KR
Lim; Jong Lae - Gyeonggi-do KR
Lim; Jong Lae - Chungcheongnam-do KR
Lim; Jong Lae - Seoul KR
Lim; Jong-Lae - Cheonan-si KR
Lim; Jong Lae - Kyeonggi-do KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable Pharmaceutical Composition Comprising Esomeprazole And Sodium Bicarbonate App 20220288045 - Choi; Jong Seo ; et al.	2022-09-15
Pharmaceutical Preparation Having Excellent Dissolution Properties, Containing Esomeprazole And Sodium Bicarbonate App 20220233514 - Choi; Jong Seo ; et al.	2022-07-28
Composition For Preventing Or Treating Gastritis Or Peptic Ulcer App 20220054571 - YOU; Jaehoon ; et al.	2022-02-24
Composition Comprising Dutasteride App 20220054508 - Park; Tae Hyun ; et al.	2022-02-24
Stable Pharmaceutical Composition Comprising Esomeprazole And Sodium Bicarbonate App 20210030786 - Choi; Jong Seo ; et al.	2021-02-04
Pharmaceutical Formulation Comprising Esomeprazole And Sodium Bicarbonate App 20210030687 - Choi; Jong Seo ; et al.	2021-02-04
Composition For Preventing Or Treating Gastritis Or Peptic Ulcer App 20200061142 - YOU; Jaehoon ; et al.	2020-02-27
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20200054766 - Kim; Jae Hyun ; et al.	2020-02-20
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20180271999 - Kim; Jae Hyun ; et al.	2018-09-27
Pharmaceutical Composition Comprising 5alpha-reductase Inhibitor App 20180207146 - AHN; Byoung Ki ; et al.	2018-07-26
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20170209596 - Kim; Jae Hyun ; et al.	2017-07-27
Composition for gene delivery Grant 9,173,853 - Lee , et al. November 3, 2	2015-11-03
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20150238634 - Kim; Jae Hyun ; et al.	2015-08-27
Novel Composition For Gene Delivery App 20150110876 - Lee; Young Nam ; et al.	2015-04-23
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20140155348 - Kim; Jae Hyun ; et al.	2014-06-05
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20130029936 - Kim; Jae Hyun ; et al.	2013-01-31
Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same App 20110034550 - Kim; Jae Hyun ; et al.	2011-02-10
Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same Grant 7,718,695 - Kim , et al. May 18, 2	2010-05-18
Pharmaceutical composition of amlodipine maleate having enhanced stability App 20090191274 - Lee; Sang-Joon ; et al.	2009-07-30
Inclusion Compounds Of Fumagillol Derivative Or Its Salt, And Pharmaceutical Compositions Comprising The Same App 20080085929 - KIM; Jae Hyun ; et al.	2008-04-10
Solid dispersion of tacrolimus App 20060177500 - Shin; Hee-Jong ; et al.	2006-08-10
Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same App 20050037994 - Kim, Jae Hyun ; et al.	2005-02-17
Pharmaceutical composition comprising cyclosporin solid-state microemulsion Grant 6,306,434 - Hong , et al. October 23, 2	2001-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.